Showing results (2491-2500 of 11,276) with videos related to

Sort By:
Pageof 1,128
Biochemical and Biophysical Research Communications|August 30, 1988
Cloned riboprobe for detection of a mycoplasmalike organismI M Lee, R E Davis, R Hammond, et al.
Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference|November 17, 2018
In vivo relationship between joint stiffness, joint-based estimates of muscle stiffness, and shear-wave velocityAndrew D Vigotsky, Elliott J Rouse, Sabrina S M Lee
Plant Disease|March 6, 2019
Comparison of Dig-Labeled PCR, Nested PCR, and ELISA for the Detection of Clavibacter michiganensis subsp. sepedonicus in Field-Grown PotatoesI-M Lee, L A Lukaesko, C J M Maroon
Genetics|December 1, 1996
Dosage suppressors of a benomyl-dependent tubulin mutant: evidence for a link between microtubule stability and cellular metabolismN A Machin, J M Lee, K Chamany, et al.
The Journal of Heredity|July 1, 1980
Pseudolinkage of the duplicate loci for supernatant aspartate aminotransferase in brook trout, Salvelinus fontinalisJ E Wright, B May, M Stoneking, et al.
Diagnostic Imaging|January 1, 1983
Computer-tomographic appearance of branchial cleft and thyroglossal duct cysts of the neckS E Byrd, M Richardson, G Gill, et al.
Methods in Molecular Biology (Clifton, N.J.)|May 19, 2023
Whole Blood Procoagulant Platelet Flow Cytometry Protocol for Heparin-Induced Thrombocytopenia (HIT) and Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT) TestingChristine S M Lee, Matthew C Powell, Vivien M Chen
Critical Reviews in Oncology/Hematology|May 15, 2023
From preclinical efficacy to 2022 (36.7 months median follow -up) updated CROWN trial, lorlatinib is the preferred 1st-line treatment of advanced ALK+ NSCLCSai-Hong Ignatius Ou, Alexandria T M Lee, Misako Nagasaka
ESMO Open|July 5, 2024
U-PRO-CRM: designing patient-centred dose-finding trials with patient-reported outcomesE Alger, S M Lee, Y K Cheung, et al.
Clinical Trials (London, England)|April 9, 2024
Dose optimization for cancer treatments with considerations for late-onset toxicitiesLucie Biard, Anaïs Andrillon, Rebecca B Silva, et al.
Pageof 1,128